Commerzbank Aktiengesellschaft’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-6,110
| Closed | -$443K | – | 764 |
|
|
2019
Q2 | $443K | Buy |
6,110
+3,816
| +166% | +$277K | ﹤0.01% | 635 |
|
|
2019
Q1 | $214K | Sell |
2,294
-2,902
| -56% | -$271K | ﹤0.01% | 729 |
|
|
2018
Q4 | $379K | Buy |
5,196
+2,511
| +94% | +$183K | ﹤0.01% | 633 |
|
|
2018
Q3 | $235K | Buy |
2,685
+249
| +10% | +$21.8K | ﹤0.01% | 769 |
|
|
2018
Q2 | $240K | Buy |
+2,436
| New | +$240K | ﹤0.01% | 752 |
|
|
2016
Q4 | – | Sell |
-3,262
| Closed | -$221K | – | 938 |
|
|
2016
Q3 | $221K | Sell |
3,262
-1,095
| -25% | -$74.2K | ﹤0.01% | 789 |
|
|
2016
Q2 | $242 | Sell |
4,357
-605
| -12% | -$34 | ﹤0.01% | 865 |
|
|
2016
Q1 | $311K | Sell |
4,962
-466
| -9% | -$29.2K | ﹤0.01% | 836 |
|
|
2015
Q4 | $511K | Buy |
5,428
+163
| +3% | +$15.3K | ﹤0.01% | 756 |
|
|
2015
Q3 | $423K | Sell |
5,265
-497
| -9% | -$39.9K | ﹤0.01% | 744 |
|
|
2015
Q2 | $691K | Buy |
5,762
+3,449
| +149% | +$414K | ﹤0.01% | 811 |
|
|
2015
Q1 | $242K | Sell |
2,313
-1,073
| -32% | -$112K | ﹤0.01% | 955 |
|
|
2014
Q4 | $328K | Buy |
+3,386
| New | +$328K | ﹤0.01% | 931 |
|